Patent · US Expired

Use of inhibitors of the sodium-hydrogen exchanger for preparing a medicament for preventing age-related disorders, and for prolonging life

US6420430B1 · kind B1 · utility

13Cited by

6References

11Claims

0Family size

Assignee

Aventis Pharma Deutschland GmbH · DE

Inventors

Wolfgang Linz · Mainz, DE
Hans-Jochen Lang · Hofheim, DE
Bela Kelety · Frankfurt am Main, DE
Peter Schmid · Santa Fe Springs, US

Key dates

Filing date	Dec 22, 1999
Grant date	Jul 16, 2002
Priority date	—
Expiry date	Dec 22, 2019

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Inhibitors of the cellular sodium-hydrogen exchanger are employed for preparing a medicament for preventing age-related functional disorders and dysfuntional changes of organs of the body and for preventing age-related diorders and for prolonging life while maintaining an improved quality of life. Typical representatives of NHE inhibitors are cariporide and eniporide

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.